B. Riley Ups Price Target on Biote to $10 From $9, Maintains Buy Rating
MT NewswiresApr 5 09:27 ET
Correction: --B. Riley Lowers Bitcoin Depot's Price Target to $4 From $6, Maintains Buy Rating
MT NewswiresApr 3 10:24 ET
Biote Analyst Ratings
BenzingaMar 13 11:09 ET
Analysts Are Bullish on Top Healthcare Stocks: Biote (BTMD), Incyte (INCY)
TipRanksMar 13 07:40 ET
Truist Financial Issues a Buy Rating on Biote (BTMD)
TipRanksFeb 27 07:48 ET
Buy Rating on Biote's Stock: A Positive Outlook Amidst Nutraceutical Challenges
TipRanksFeb 20 21:15 ET
Biote Analyst Ratings
BenzingaFeb 20 06:37 ET
Biote Analyst Ratings
BenzingaFeb 1 08:00 ET
Biote Analyst Ratings
BenzingaJan 18 09:02 ET
TD Cowen Maintains Outperform on Biote, Lowers Price Target to $7
BenzingaAug 15, 2023 08:17 ET
Biote Analyst Ratings
BenzingaAug 15, 2023 08:16 ET
Biote Analyst Ratings
BenzingaAug 14, 2023 09:53 ET
Roth MKM Adjusts Price Target on Biote to $11 From $10, Maintains Buy Rating
MT NewswiresMar 30, 2023 10:38 ET
Roth MKM Maintains Buy on Biote, Raises Price Target to $11
BenzingaMar 30, 2023 10:13 ET
Biote Analyst Ratings
Benzinga Analyst RatingsSep 27, 2022 07:18 ET
Truist Securities Starts Biote at Buy With $10 Price Target
MT NewswiresSep 27, 2022 06:30 ET
Biote Initiated at Outperform by Cowen & Co.
Dow JonesJun 24, 2022 07:39 ET
Biote Price Target Announced at $11.00/Share by Cowen & Co.
Dow JonesJun 24, 2022 07:39 ET
Biote analyst ratings
Benzinga Analyst RatingsJun 24, 2022 07:30 ET
Cowen & Co. Initiates Coverage On Biote with Outperform Rating, Announces Price Target of $11
Benzinga Real-time NewsJun 24, 2022 07:30 ET
No Data
No Data